Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study. En savoir plus sur Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas. En savoir plus sur Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas.